Acumen Pharmaceuticals Files Form 8-K
Acumen Pharmaceuticals filed a Form 8-K on October 30.
Related stories
Nasdaq Slides More Than 2%, S&P 500 Falls More Than 1%
The Nasdaq fell more than 2%, while the S&P 500 declined more than 1%; the Dow also dipped. Employment cost growth cooled in Q3.
M impact | EQUITY | Oct 30, 2026, 02:57 PM UTC
S&P 500 Energy Index Hits Record High as Oil Rallies
The S&P 500 energy index hit a record high as an oil rally lifted the sector.
M impact | EQUITY | Oct 30, 2026, 02:57 PM UTC
TSX Falls 1.57% as Gold Slump and Tech Weakness Weigh
Canada’s S&P/TSX Composite Index was down 1.57% at 35,673.99 points as of 10:33 a.m. ET, after hitting a one-week low. Mining and technology stocks declined.
M impact | EQUITY | Oct 30, 2026, 02:52 PM UTC
Regeneron shares rise 11.3% to nearly two-year high after quarterly results exceed expectations
Regeneron shares rose 11.3% to 91, reaching a nearly two-year high after quarterly results exceeded expectations.
M impact | EQUITY | Oct 30, 2026, 02:51 PM UTC
Reddit Shares Tumble More Than 25% After Search Traffic Warning
Reddit shares fell more than 25% Friday morning after a warning about search traffic and user volume in the months ahead. Third-quarter revenue rose more than 50%, but Reddit misse
M impact | EQUITY | Oct 30, 2026, 02:44 PM UTC
ExxonMobil CEO Says Company Intends to Grow Natural Gas Portfolio
M impact | EQUITY | Oct 30, 2026, 02:40 PM UTC